baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UBS Knock-Out DTE/ DE000UL38ZM2 /

23.05.2024 16:46:12	Изменение+0.25	Бид22:00:13	Предложение22:00:13	Базовый актив	Цена исполнения	Дата истечения	Тип опциона
11.00EUR	+2.33%	- Величина цены спроса: -	- Величина цены предложения: -	DT.TELEKOM AG NA	32.712 EUR	31.12.2078	Put

GlobeNewswire 23:13 SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Onc...

TeleTrader 23:13 SEC approves Ethereum ETFs

GlobeNewswire 23:11 Special Olympics Florida and Orlando Health Announce Five-Year Partnership

GlobeNewswire 23:10 Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-10...

GlobeNewswire 23:09 Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant impr...

GlobeNewswire 23:06 G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (A...

GlobeNewswire 23:05 Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting

GlobeNewswire 23:05 BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upco...

GlobeNewswire 23:05 I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...

GlobeNewswire 23:05 Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...

GlobeNewswire 23:05 Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer

GlobeNewswire 23:05 FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...

GlobeNewswire 23:05 NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...

GlobeNewswire 23:05 Elcora Announces Share Consolidation

GlobeNewswire 23:05 Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study i...

GlobeNewswire 23:04 Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...

GlobeNewswire 23:03 Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...

GlobeNewswire 23:01 Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...

GlobeNewswire 23:01 Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...

GlobeNewswire 23:01 HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical...

GlobeNewswire 23:00 Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Co...

TeleTrader 23:00 Iran-backed militia claims drone attack on Eilat

GlobeNewswire 23:00 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term E...

GlobeNewswire 23:00 Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...

GlobeNewswire 23:00 Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting

UBS Knock-Out DTE/ DE000UL38ZM2 /

Если вы хотите получить ответ на свой отзыв, укажите, пожалуйста, адрес своей электронной почты.